Literature DB >> 31852793

An Animal Model That Mimics Human Herpesvirus 6B Pathogenesis.

Bochao Wang1, Yasuyuki Saito2, Mitsuhiro Nishimura1, Zhenxiao Ren1, Lidya Handayani Tjan1, Alaa Refaat2, Rie Iida-Norita2, Ryuko Tsukamoto3, Masato Komatsu3, Tomoo Itoh3, Takashi Matozaki2, Yasuko Mori4.   

Abstract

Human herpesvirus 6B (HHV-6B), a T-lymphotropic virus, infects almost exclusively humans. An animal model of HHV-6B has not been available. Here, we report the first animal model to mimic HHV-6B pathogenesis; the model is based on humanized mice in which human immune cells were engrafted and maintained. For HHV-6B replication, adequate human T-cell activation (which becomes susceptible to HHV-6B) is necessary in this murine model. Here, we found that an additional transfer of human mononuclear cells to humanized mice resulted in an explosive proliferation of human activated T cells, which could be representative of graft-versus-host disease (GVHD) because the primary transfer of human cells was not sufficient to increase the number and ratio of human T cells. Mice infected with HHV-6B became weak and/or died approximately 7 to 14 days later. Quantitative PCR analysis revealed that the spleen and lungs were the major sites of HHV-6B replication in this model, and this was corroborated by the detection of viral proteins in these organs. Histological analysis also revealed the presence of megakaryocytes, indicating HHV-6B infection. Multiplex analysis of cytokines/chemokines in sera from the infected mice showed secretions of human cytokines/chemokines as reported for both in vitro infection and clinical samples, indicating that the secreted cytokines could affect pathogenesis. This is the first animal model showing HHV-6B pathogenesis, and it will be useful for elucidating the pathogenicity of HHV-6B, which is related to GVHD and idiopathic pneumonia syndrome.IMPORTANCE Human herpesvirus 6B (HHV-6B) is a ubiquitous virus that establishes lifelong latent infection only in humans, and the infection can reactivate, with severe complications that cause major problems. A small-animal model of HHV-6B infection has thus been desired for research regarding the pathogenicity of HHV-6B and the development of antiviral agents. We generated humanized mice by transplantation with human hematopoietic stem cells, and here, we modified the model by providing an additional transfer of human mononuclear cells, providing the proper conditions for efficient HHV-6B infection. This is the first humanized mouse model to mimic HHV-6B pathogenesis, and it has great potential for research into the in vivo pathogenesis of HHV-6B.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  HHV-6B; animal model; graft-versus-host disease; human herpesvirus 6B; humanized mouse; idiopathic pneumonia syndrome; pathogenesis

Mesh:

Year:  2020        PMID: 31852793      PMCID: PMC7158738          DOI: 10.1128/JVI.01851-19

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  CD134-allodepletion allows selective elimination of alloreactive human T cells without loss of virus-specific and leukemia-specific effectors.

Authors:  Xupeng Ge; Julia Brown; Megan Sykes; Vassiliki A Boussiotis
Journal:  Biol Blood Marrow Transplant       Date:  2008-05       Impact factor: 5.742

2.  Early human herpesvirus type 6 reactivation after allogeneic stem cell transplantation: a large-scale clinical study.

Authors:  Rémy Dulery; Julia Salleron; Anny Dewilde; Julien Rossignol; Eileen M Boyle; Julie Gay; Eva de Berranger; Valerie Coiteux; Jean-Pierre Jouet; Alain Duhamel; Ibrahim Yakoub-Agha
Journal:  Biol Blood Marrow Transplant       Date:  2011-12-30       Impact factor: 5.742

3.  Human CD134 (OX40) expressed on T cells plays a key role for human herpesvirus 6B replication after allogeneic hematopoietic stem cell transplantation.

Authors:  Satoshi Nagamata; Miwako Nagasaka; Akiko Kawabata; Kenji Kishimoto; Daiichiro Hasegawa; Yoshiyuki Kosaka; Takeshi Mori; Ichiro Morioka; Noriyuki Nishimura; Kazumoto Iijima; Hideto Yamada; Shinichiro Kawamoto; Kimikazu Yakushijin; Hiroshi Matsuoka; Yasuko Mori
Journal:  J Clin Virol       Date:  2018-02-21       Impact factor: 3.168

4.  B Lymphocyte Chemoattractant (CXCL13) Is an Indicator of Acute Gastrointestinal GVHD in Murine Model.

Authors:  Yigeng Cao; Xiaoyi Qin; Na Wang; Erlie Jiang; Mingzhe Han; Yongyong Ma; Bin Liang; Kaiyan Yang; Kang Yu; Haige Ye
Journal:  Inflammation       Date:  2017-10       Impact factor: 4.092

5.  Idiopathic pneumonia syndrome after hematopoietic cell transplantation: evidence of occult infectious etiologies.

Authors:  Sachiko Seo; Christian Renaud; Jane M Kuypers; Charles Y Chiu; Meei-Li Huang; Erik Samayoa; Hu Xie; Guixia Yu; Cynthia E Fisher; Ted A Gooley; Steven Miller; Robert C Hackman; David Myerson; Ruth H Sedlak; Yae-Jean Kim; Takahiro Fukuda; David N Fredricks; David K Madtes; Keith R Jerome; Michael Boeckh
Journal:  Blood       Date:  2015-04-27       Impact factor: 22.113

6.  Human peripheral blood xenografts in the SCID mouse: characterization of immunologic reconstitution.

Authors:  R M Hesselton; R A Koup; M A Cromwell; B S Graham; M Johns; J L Sullivan
Journal:  J Infect Dis       Date:  1993-09       Impact factor: 5.226

7.  The fate of human peripheral blood lymphocytes after transplantation into SCID mice.

Authors:  G Martino; J Anastasi; J Feng; C Mc Shan; L DeGroot; J Quintans; L M Grimaldi
Journal:  Eur J Immunol       Date:  1993-05       Impact factor: 5.532

8.  Experimental infection of cynomolgus and African green monkeys with human herpesvirus 6.

Authors:  S Yalcin; T Mukai; K Kondo; Y Ami; T Okawa; A Kojima; T Kurata; K Yamanishi
Journal:  J Gen Virol       Date:  1992-07       Impact factor: 3.891

9.  High level functional engraftment of severe combined immunodeficient mice with human peripheral blood lymphocytes following pretreatment with radiation and anti-asialo GM1.

Authors:  B Shpitz; C A Chambers; A B Singhal; N Hozumi; B J Fernandes; C M Roifman; L M Weiner; J C Roder; S Gallinger
Journal:  J Immunol Methods       Date:  1994-02-28       Impact factor: 2.303

10.  Human Herpesvirus-6B Reactivation Is a Risk Factor for Grades II to IV Acute Graft-versus-Host Disease after Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.

Authors:  Tuan L Phan; Kristen Carlin; Per Ljungman; Ioannis Politikos; Vicki Boussiotis; Michael Boeckh; Michele L Shaffer; Danielle M Zerr
Journal:  Biol Blood Marrow Transplant       Date:  2018-04-21       Impact factor: 5.742

View more
  4 in total

1.  Human Herpesvirus 6A Tegument Protein U14 Induces NF-κB Signaling by Interacting with p65.

Authors:  Salma Aktar; Jun Arii; Lidya Handayani Tjan; Mitsuhiro Nishimura; Yasuko Mori
Journal:  J Virol       Date:  2021-09-22       Impact factor: 5.103

2.  ATF1 Restricts Human Herpesvirus 6A Replication via Beta Interferon Induction.

Authors:  Salma Aktar; Jun Arii; Thi Thu Huong Nguyen; Jing Rin Huang; Mitsuhiro Nishimura; Yasuko Mori
Journal:  J Virol       Date:  2022-09-26       Impact factor: 6.549

3.  Murine roseolovirus does not accelerate amyloid-β pathology and human roseoloviruses are not over-represented in Alzheimer disease brains.

Authors:  Tarin M Bigley; Monica Xiong; Muhammad Ali; Yun Chen; Chao Wang; Javier Remolina Serrano; Abdallah Eteleeb; Oscar Harari; Liping Yang; Swapneel J Patel; Carlos Cruchaga; Wayne M Yokoyama; David M Holtzman
Journal:  Mol Neurodegener       Date:  2022-01-15       Impact factor: 18.879

4.  Disruption of thymic central tolerance by infection with murine roseolovirus induces autoimmune gastritis.

Authors:  Tarin M Bigley; Liping Yang; Liang-I Kang; Jose B Saenz; Francisco Victorino; Wayne M Yokoyama
Journal:  J Exp Med       Date:  2022-02-28       Impact factor: 17.579

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.